These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26558635)

  • 21. Intralesional immunotherapy for pediatric warts: A review.
    Fields JR; Saikaly SK; Schoch JJ
    Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of Nevi After Candida Injection for the Treatment of Verruca Vulgaris.
    Kollmann E; Cleaver D; Cleaver L; Cleaver J
    Pediatr Dermatol; 2017 Mar; 34(2):199-200. PubMed ID: 27981626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.
    Kim KH; Horn TD; Pharis J; Kincannon J; Jones R; O'Bryan K; Myers J; Nakagawa M
    Arch Dermatol; 2010 Dec; 146(12):1431-3. PubMed ID: 21173332
    [No Abstract]   [Full Text] [Related]  

  • 24. Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts.
    Youssef EMK; Eissa MAA; Bakr RM
    Arch Dermatol Res; 2023 Jul; 315(5):1305-1314. PubMed ID: 36567351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
    Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
    Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.
    Johnson SM; Horn TD
    J Drugs Dermatol; 2004; 3(3):263-5. PubMed ID: 15176159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
    Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
    J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood toll-like receptor 4 correlates response to candida immunotherapy of warts.
    Sabry HH; Hamed AM; Salem RM; Marei AM; El Sebaey RM
    Dermatol Ther; 2018 Sep; 31(5):e12691. PubMed ID: 30226014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mannose binding lectin in response to candida antigen immunotherapy of warts.
    Nasr M; Marie A; Boghdadi G; Elsaid R; Salah E
    J Dermatolog Treat; 2021 Jun; 32(4):376-380. PubMed ID: 31469597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intralesional immunotherapy for genital warts.
    King M; Johnson SM; Horn TD
    Arch Dermatol; 2005 Dec; 141(12):1606-7. PubMed ID: 16365274
    [No Abstract]   [Full Text] [Related]  

  • 31. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
    Nofal A; Adel L; Fawzy M; Elkholy BM
    Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
    Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
    Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of intralesional Candida antigen in diabetic patients with multiple warts.
    Marei A; Alakad R; Wahid RM
    J Cosmet Dermatol; 2021 Apr; 20(4):1248-1253. PubMed ID: 32924256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement component 3c and tumor necrosis factor-α systemic assessment after Candida antigen immunotherapy in cutaneous warts.
    Hammad NM; Abdelhadi AA; Fawzy MM; Marei A
    Braz J Microbiol; 2020 Dec; 51(4):1673-1681. PubMed ID: 32594377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of flat warts using intralesional Candida antigen.
    Ritter SE; Meffert J
    Arch Dermatol; 2003 Apr; 139(4):541-2. PubMed ID: 12707109
    [No Abstract]   [Full Text] [Related]  

  • 36. Candida albicans Immunotherapy for Verrucae Plantaris.
    Vlahovic TC; Spadone S; Dunn SP; Fussell T; Hersh I; Green T; Merrill J; Ghosh P; Tran T
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):395-400. PubMed ID: 26429607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional antigen immunotherapy for the treatment of plane warts: A comparative study.
    Fawzy MM; Nofal A; Alakad R
    Dermatol Ther; 2020 Nov; 33(6):e13807. PubMed ID: 32530550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Cryo-immuno-therapy' is superior to intralesional
    Attwa E; Elawady R; Salah E
    J Dermatolog Treat; 2021 Dec; 32(8):1018-1025. PubMed ID: 32009473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
    Tawfik NZ; Eyada MMK; Abdel El Hamid RE; Halim HM
    Dermatol Ther; 2022 Oct; 35(10):e15762. PubMed ID: 36056784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
    Abdel Razik LH; Obaid ZM; Fouda I
    J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.